Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.

Advances in therapy

Omboni S, Malacco E, Napoli C, Modesti PA, Manolis A, Parati G, Agabiti-Rosei E, Borghi C.
PMID: 28452039
Adv Ther. 2017 Jun;34(6):1498-1499. doi: 10.1007/s12325-017-0537-4.

No abstract available.

Cite
Omboni S, Malacco E, Napoli C, et al. Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies. Adv Ther. 2017;34(6):1498-1499doi: 10.1007/s12325-017-0537-4.
Omboni, S., Malacco, E., Napoli, C., Modesti, P. A., Manolis, A., Parati, G., Agabiti-Rosei, E., & Borghi, C. (2017). Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies. Advances in therapy, 34(6), 1498-1499. https://doi.org/10.1007/s12325-017-0537-4
Omboni, Stefano, et al. "Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies." Advances in therapy vol. 34,6 (2017): 1498-1499. doi: https://doi.org/10.1007/s12325-017-0537-4
Omboni S, Malacco E, Napoli C, Modesti PA, Manolis A, Parati G, Agabiti-Rosei E, Borghi C. Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies. Adv Ther. 2017 Jun;34(6):1498-1499. doi: 10.1007/s12325-017-0537-4. PMID: 28452039; PMCID: PMC5487858.
Copy Download .nbib Format: NLM
Expertise: No Longer a Sine Qua Non for Guideline Authors?.

Hypertension (Dallas, Tex. : 1979)

Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B.
PMID: 28652465
Hypertension. 2017 Aug;70(2):235-237. doi: 10.1161/HYPERTENSIONAHA.117.09470. Epub 2017 Jun 26.

No abstract available.

Cite
Messerli FH, Hofstetter L, Agabiti-Rosei E, et al. Expertise: No Longer a Sine Qua Non for Guideline Authors?. Hypertension. 2017;70(2):235-237doi: 10.1161/HYPERTENSIONAHA.117.09470.
Messerli, F. H., Hofstetter, L., Agabiti-Rosei, E., Burnier, M., Elliott, W. J., Franklin, S. S., Grodzicki, T., Kario, K., Kjeldsen, S. E., Kostis, J. B., Laurent, S., Leenen, F. H., Lund-Johansen, P., Mancia, G., Narkiewicz, K., Papademetriou, V., Parati, G., Poulter, N., Redon, J., Rimoldi, S. F., Ruilope, L. M., Schiffrin, E. L., Schmieder, R. E., Schwartz, A. B., Sever, P., Sowers, J. R., Staessen, J. A., Wang, J., Weber, M., & Williams, B. (2017). Expertise: No Longer a Sine Qua Non for Guideline Authors?. Hypertension (Dallas, Tex. : 1979), 70(2), 235-237. https://doi.org/10.1161/HYPERTENSIONAHA.117.09470
Messerli, Franz H, et al. "Expertise: No Longer a Sine Qua Non for Guideline Authors?." Hypertension (Dallas, Tex. : 1979) vol. 70,2 (2017): 235-237. doi: https://doi.org/10.1161/HYPERTENSIONAHA.117.09470
Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B. Expertise: No Longer a Sine Qua Non for Guideline Authors?. Hypertension. 2017 Aug;70(2):235-237. doi: 10.1161/HYPERTENSIONAHA.117.09470. Epub 2017 Jun 26. PMID: 28652465.
Copy Download .nbib Format: NLM
The Vobarno Study.

Panminerva medica

Agabiti Rosei E, Muiesan ML, Salvetti M, Paini A, Agabiti Rosei C, Aggiusti C, Bertacchini F, Castellano M, Giacchè M.
PMID: 33988330
Panminerva Med. 2021 Dec;63(4):458-463. doi: 10.23736/S0031-0808.21.04433-5. Epub 2021 May 14.

The Vobarno Study represents the first observational study aimed to assess in a general population sample the relationship between parameters of cardiac and vascular structure (and function) and blood pressure values, measured in the clinic and during the 24...

Cite
Agabiti Rosei E, Muiesan ML, Salvetti M, et al. The Vobarno Study. Panminerva Med. 2021;63(4):458-463doi: 10.23736/S0031-0808.21.04433-5.
Agabiti Rosei, E., Muiesan, M. L., Salvetti, M., Paini, A., Agabiti Rosei, C., Aggiusti, C., Bertacchini, F., Castellano, M., & Giacchè, M. (2021). The Vobarno Study. Panminerva medica, 63(4), 458-463. https://doi.org/10.23736/S0031-0808.21.04433-5
Agabiti Rosei, Enrico, et al. "The Vobarno Study." Panminerva medica vol. 63,4 (2021): 458-463. doi: https://doi.org/10.23736/S0031-0808.21.04433-5
Agabiti Rosei E, Muiesan ML, Salvetti M, Paini A, Agabiti Rosei C, Aggiusti C, Bertacchini F, Castellano M, Giacchè M. The Vobarno Study. Panminerva Med. 2021 Dec;63(4):458-463. doi: 10.23736/S0031-0808.21.04433-5. Epub 2021 May 14. PMID: 33988330.
Copy Download .nbib Format: NLM
Microcirculation and Macrocirculation in Hypertension: A Dangerous Cross-Link?.

Hypertension (Dallas, Tex. : 1979)

Laurent S, Agabiti-Rosei C, Bruno RM, Rizzoni D.
PMID: 34984924
Hypertension. 2022 Jan 05;HYPERTENSIONAHA12117962. doi: 10.1161/HYPERTENSIONAHA.121.17962. Epub 2022 Jan 05.

Microcirculation and macrocirculation are tightly interconnected into a dangerous cross-link in hypertension. Small artery damage includes functional (vasoconstriction, impaired vasodilatation) and structural abnormalities (mostly inward eutrophic remodeling). These abnormalities are major determinants of the increase in total peripheral resistance...

Cite
Laurent S, Agabiti-Rosei C, Bruno RM, et al. Microcirculation and Macrocirculation in Hypertension: A Dangerous Cross-Link?. Hypertension. 2022;HYPERTENSIONAHA12117962doi: 10.1161/HYPERTENSIONAHA.121.17962.
Laurent, S., Agabiti-Rosei, C., Bruno, R. M., & Rizzoni, D. (2022). Microcirculation and Macrocirculation in Hypertension: A Dangerous Cross-Link?. Hypertension (Dallas, Tex. : 1979), HYPERTENSIONAHA12117962. https://doi.org/10.1161/HYPERTENSIONAHA.121.17962
Laurent, Stephane, et al. "Microcirculation and Macrocirculation in Hypertension: A Dangerous Cross-Link?." Hypertension (Dallas, Tex. : 1979) vol. (2022): HYPERTENSIONAHA12117962. doi: https://doi.org/10.1161/HYPERTENSIONAHA.121.17962
Laurent S, Agabiti-Rosei C, Bruno RM, Rizzoni D. Microcirculation and Macrocirculation in Hypertension: A Dangerous Cross-Link?. Hypertension. 2022 Jan 05;HYPERTENSIONAHA12117962. doi: 10.1161/HYPERTENSIONAHA.121.17962. Epub 2022 Jan 05. PMID: 34984924.
Copy Download .nbib Format: NLM
Uric Acid and Cardiovascular Disease: An Update.

European cardiology

Muiesan ML, Agabiti-Rosei C, Paini A, Salvetti M.
PMID: 30310447
Eur Cardiol. 2016 Aug;11(1):54-59. doi: 10.15420/ecr.2016:4:2.

In recent years, serum uric acid (SUA) as a determinant of cardiovascular (CV) risk has gained interest. Epidemiological, experimental and clinical data show that patients with hyperuricaemia SUA are at increased risk of cardiac, renal and vascular damage and...

Cite
Muiesan ML, Agabiti-Rosei C, Paini A, et al. Uric Acid and Cardiovascular Disease: An Update. Eur Cardiol. 2016;11(1):54-59doi: 10.15420/ecr.2016:4:2.
Muiesan, M. L., Agabiti-Rosei, C., Paini, A., & Salvetti, M. (2016). Uric Acid and Cardiovascular Disease: An Update. European cardiology, 11(1), 54-59. https://doi.org/10.15420/ecr.2016:4:2
Muiesan, Maria Lorenza, et al. "Uric Acid and Cardiovascular Disease: An Update." European cardiology vol. 11,1 (2016): 54-59. doi: https://doi.org/10.15420/ecr.2016:4:2
Muiesan ML, Agabiti-Rosei C, Paini A, Salvetti M. Uric Acid and Cardiovascular Disease: An Update. Eur Cardiol. 2016 Aug;11(1):54-59. doi: 10.15420/ecr.2016:4:2. PMID: 30310447; PMCID: PMC6159425.
Copy Download .nbib Format: NLM
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

Journal of hypertension

Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A.
PMID: 19838131
J Hypertens. 2009 Nov;27(11):2121-58. doi: 10.1097/HJH.0b013e328333146d.

No abstract available.

Cite
Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27(11):2121-58doi: 10.1097/HJH.0b013e328333146d.
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., Erdine, S., Fagard, R., Farsang, C., Grassi, G., Haller, H., Heagerty, A., Kjeldsen, S. E., Kiowski, W., Mallion, J. M., Manolis, A., Narkiewicz, K., Nilsson, P., Olsen, M. H., Rahn, K. H., Redon, J., Rodicio, J., Ruilope, L., Schmieder, R. E., Struijker-Boudier, H. A., van Zwieten, P. A., Viigimaa, M., Zanchetti, A. (2009). Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Journal of hypertension, 27(11), 2121-58. https://doi.org/10.1097/HJH.0b013e328333146d
Mancia, Giuseppe, et al. "Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document." Journal of hypertension vol. 27,11 (2009): 2121-58. doi: https://doi.org/10.1097/HJH.0b013e328333146d
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009 Nov;27(11):2121-58. doi: 10.1097/HJH.0b013e328333146d. PMID: 19838131.
Copy Download .nbib Format: NLM
[Practice guidelines 2007 for the treatment of arterial hypertension].

Giornale italiano di cardiologia (2006)

Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germanò G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Dalby Kristensen S, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Manolis A, Nilsson PM, Redon J, Viigimaa M.
PMID: 17695132
G Ital Cardiol (Rome). 2007 Jul;8(7):389-479.

No abstract available.

Cite
Mancia G, De Backer G, Dominiczak A, et al. Linee guida 2007 per il trattamento dell'ipertensione arteriosa. [Practice guidelines 2007 for the treatment of arterial hypertension]. G Ital Cardiol (Rome). 2007;8(7):389-479
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germanò, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker Boudier, H. A., Zanchetti, A., Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Dalby Kristensen, S., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Erdine, S., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Lindholm, L. H., Manolis, A., Nilsson, P. M., Redon, J., Viigimaa, M. (2007). Linee guida 2007 per il trattamento dell'ipertensione arteriosa. [Practice guidelines 2007 for the treatment of arterial hypertension]. Giornale italiano di cardiologia (2006), 8(7), 389-479.
Mancia, Giuseppe, et al. "Linee guida 2007 per il trattamento dell'ipertensione arteriosa." [Practice guidelines 2007 for the treatment of arterial hypertension]. Giornale italiano di cardiologia (2006) vol. 8,7 (2007): 389-479.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germanò G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Dalby Kristensen S, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Manolis A, Nilsson PM, Redon J, Viigimaa M. Linee guida 2007 per il trattamento dell'ipertensione arteriosa. [Practice guidelines 2007 for the treatment of arterial hypertension]. G Ital Cardiol (Rome). 2007 Jul;8(7):389-479. Italian. PMID: 17695132.
Copy Download .nbib Format: NLM
Reply.

Journal of hypertension

Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, de Leeuw PW, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B.
PMID: 28953595
J Hypertens. 2017 Nov;35(11):2327-2328. doi: 10.1097/HJH.0000000000001526.

No abstract available.

Cite
Messerli FH, Hofstetter L, Agabiti-Rosei E, et al. Reply. J Hypertens. 2017;35(11):2327-2328doi: 10.1097/HJH.0000000000001526.
Messerli, F. H., Hofstetter, L., Agabiti-Rosei, E., Burnier, M., Elliott, W. J., Franklin, S. S., Grodzicki, T., Kario, K., Kjeldsen, S. E., Kostis, J. B., Laurent, S., Leenen, F. H., de Leeuw, P. W., Lund-Johansen, P., Mancia, G., Narkiewicz, K., Papademetriou, V., Parati, G., Poulter, N., Redon, J., Rimoldi, S. F., Ruilope, L. M., Schiffrin, E. L., Schmieder, R. E., Schwartz, A. B., Sever, P., Sowers, J. R., Staessen, J. A., Wang, J., Weber, M., & Williams, B. (2017). Reply. Journal of hypertension, 35(11), 2327-2328. https://doi.org/10.1097/HJH.0000000000001526
Messerli, Franz H, et al. "Reply." Journal of hypertension vol. 35,11 (2017): 2327-2328. doi: https://doi.org/10.1097/HJH.0000000000001526
Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, de Leeuw PW, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B. Reply. J Hypertens. 2017 Nov;35(11):2327-2328. doi: 10.1097/HJH.0000000000001526. PMID: 28953595.
Copy Download .nbib Format: NLM
Commentary On "Pathways Of Microcirculatory Endothelial Dysfunction In Osa: A Comprehensive Ex Vivo Evaluation In Human Tissue".

American journal of hypertension

Rizzoni D, De Ciuceis C, Agabiti-Rosei C.
PMID: 34788789
Am J Hypertens. 2021 Nov 12; doi: 10.1093/ajh/hpab176. Epub 2021 Nov 12.

No abstract available.

Cite
Rizzoni D, De Ciuceis C, Agabiti-Rosei C. Commentary On "Pathways Of Microcirculatory Endothelial Dysfunction In Osa: A Comprehensive Ex Vivo Evaluation In Human Tissue". Am J Hypertens. 2021;doi: 10.1093/ajh/hpab176.
Rizzoni, D., De Ciuceis, C., & Agabiti-Rosei, C. (2021). Commentary On "Pathways Of Microcirculatory Endothelial Dysfunction In Osa: A Comprehensive Ex Vivo Evaluation In Human Tissue". American journal of hypertension, . https://doi.org/10.1093/ajh/hpab176
Rizzoni, Damiano, et al. "Commentary On "Pathways Of Microcirculatory Endothelial Dysfunction In Osa: A Comprehensive Ex Vivo Evaluation In Human Tissue"." American journal of hypertension vol. (2021). doi: https://doi.org/10.1093/ajh/hpab176
Rizzoni D, De Ciuceis C, Agabiti-Rosei C. Commentary On "Pathways Of Microcirculatory Endothelial Dysfunction In Osa: A Comprehensive Ex Vivo Evaluation In Human Tissue". Am J Hypertens. 2021 Nov 12; doi: 10.1093/ajh/hpab176. Epub 2021 Nov 12. PMID: 34788789.
Copy Download .nbib Format: NLM
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs.

Frontiers in cardiovascular medicine

Coschignano MA, De Ciuceis C, Agabiti-Rosei C, Brami V, Rossini C, Chiarini G, Malerba P, Famà F, Cosentini D, Muiesan ML, Salvetti M, Petelca A, Capellini S, Arnoldi C, Nardin M, Grisanti S, Rizzoni D, Berruti A, Paini A.
PMID: 33778028
Front Cardiovasc Med. 2021 Mar 10;8:651594. doi: 10.3389/fcvm.2021.651594. eCollection 2021.

No abstract available.

Cite
Coschignano MA, De Ciuceis C, Agabiti-Rosei C, et al. Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs. Front Cardiovasc Med. 2021;8:651594doi: 10.3389/fcvm.2021.651594.
Coschignano, M. A., De Ciuceis, C., Agabiti-Rosei, C., Brami, V., Rossini, C., Chiarini, G., Malerba, P., Famà, F., Cosentini, D., Muiesan, M. L., Salvetti, M., Petelca, A., Capellini, S., Arnoldi, C., Nardin, M., Grisanti, S., Rizzoni, D., Berruti, A., & Paini, A. (2021). Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs. Frontiers in cardiovascular medicine, 8651594. https://doi.org/10.3389/fcvm.2021.651594
Coschignano, Maria Antonietta, et al. "Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs." Frontiers in cardiovascular medicine vol. 8 (2021): 651594. doi: https://doi.org/10.3389/fcvm.2021.651594
Coschignano MA, De Ciuceis C, Agabiti-Rosei C, Brami V, Rossini C, Chiarini G, Malerba P, Famà F, Cosentini D, Muiesan ML, Salvetti M, Petelca A, Capellini S, Arnoldi C, Nardin M, Grisanti S, Rizzoni D, Berruti A, Paini A. Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs. Front Cardiovasc Med. 2021 Mar 10;8:651594. doi: 10.3389/fcvm.2021.651594. eCollection 2021. PMID: 33778028; PMCID: PMC7987651.
Copy Download .nbib Format: NLM
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.

Journal of hypertension

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G.
PMID: 26780185
J Hypertens. 2016 Mar;34(3):393-6. doi: 10.1097/HJH.0000000000000853.

No abstract available.

Cite
Zanchetti A, Liu L, Mancia G, et al. Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. J Hypertens. 2016;34(3):393-6doi: 10.1097/HJH.0000000000000853.
Zanchetti, A., Liu, L., Mancia, G., Parati, G., Grassi, G., Stramba-Badiale, M., Silani, V., Bilo, G., Corrao, G., Zambon, A., Scotti, L., Zhang, X., Guan, T. R., Zhang, Y., Zhang, X., Berge, E., Redon, J., Narkiewicz, K., Dominiczak, A., Nilsson, P., Viigimaa, M., Laurent, S., Agabiti-Rosei, E., Wu, Z., Zhu, D., Rodicio, J. L., Ruilope, L. M., Martell-Claros, N., Pinto, F., Schmieder, R. E., Burnier, M., Banach, M., Cifkova, R., Farsang, C., Konradi, A., Lazareva, I., Sirenko, Y., Dorobantu, M., Postadzhiyan, A., Accetto, R., Jelakovic, B., Lovic, D., Manolis, A. J., Stylianou, P., Dicker, D., Wei, G., Xu, C., Xie, H., Coca, A., O'Brien, J., Ford, G. (2016). Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. Journal of hypertension, 34(3), 393-6. https://doi.org/10.1097/HJH.0000000000000853
Zanchetti, Alberto, et al. "Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke." Journal of hypertension vol. 34,3 (2016): 393-6. doi: https://doi.org/10.1097/HJH.0000000000000853
Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G. Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. J Hypertens. 2016 Mar;34(3):393-6. doi: 10.1097/HJH.0000000000000853. PMID: 26780185.
Copy Download .nbib Format: NLM
Reply.

Journal of hypertension

Muiesan ML, Paini A, Colonetti E, Tarozzi L, Bertacchini F, Aggiusti C, Stassaldi D, Agabiti Rosei C, Salvetti M.
PMID: 32028519
J Hypertens. 2020 Mar;38(3):557-558. doi: 10.1097/HJH.0000000000002309.

No abstract available.

Cite
Muiesan ML, Paini A, Colonetti E, et al. Reply. J Hypertens. 2020;38(3):557-558doi: 10.1097/HJH.0000000000002309.
Muiesan, M. L., Paini, A., Colonetti, E., Tarozzi, L., Bertacchini, F., Aggiusti, C., Stassaldi, D., Agabiti Rosei, C., & Salvetti, M. (2020). Reply. Journal of hypertension, 38(3), 557-558. https://doi.org/10.1097/HJH.0000000000002309
Muiesan, Maria Lorenza, et al. "Reply." Journal of hypertension vol. 38,3 (2020): 557-558. doi: https://doi.org/10.1097/HJH.0000000000002309
Muiesan ML, Paini A, Colonetti E, Tarozzi L, Bertacchini F, Aggiusti C, Stassaldi D, Agabiti Rosei C, Salvetti M. Reply. J Hypertens. 2020 Mar;38(3):557-558. doi: 10.1097/HJH.0000000000002309. PMID: 32028519.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries